Home
Amneal Pharmaceuticals AMRX spent $240K on lobbying in Q2 2024 · Health Issues
Trade details
- Type
- Lobbying report
- Amount
- $240,000
- Quarter
- Q2 2024
- Client
- Amneal Pharmaceuticals
- Reported
- 24/07/22
Down 71.8% from last quarter
What else happened in Amneal Pharmaceuticals around then
Filed or reported within 30 days of the trade day · 24/05/31~24/07/30Amneal Pharmaceuticals's other lobbying reports
- Amneal Pharmaceuticals
LobbyingAmneal Pharmaceuticals
LobbyingAmneal Pharmaceuticals
AMRX
$190K
$190K
Reported 07/20
for Q2
- Amneal Pharmaceuticals
LobbyingAmneal Pharmaceuticals
LobbyingAmneal Pharmaceuticals
AMRX
$20K
$20K
Reported 07/17
for Q2
- Amneal Pharmaceuticals
LobbyingAmneal Pharmaceuticals
LobbyingAmneal Pharmaceuticals
AMRX
$60K
$60K
Reported 07/16
for Q2
- Amneal Pharmaceuticals
LobbyingAmneal Pharmaceuticals
LobbyingAmneal Pharmaceuticals
AMRX
$190K
$190K
Reported 04/20
for Q1
- Amneal Pharmaceuticals
LobbyingAmneal Pharmaceuticals
LobbyingAmneal Pharmaceuticals
AMRX
$60K
$60K
Reported 04/20
for Q1